Moreover, sales may be impacted by international and domestic trends toward managed care and health care cost containment and the reimbursement policies imposed by third-party payers as well as legislation affecting biopharmaceutical pricing and reimbursement.
Forward Looking Statement
This press release contains forward-looking statements based on current plans, estimates and beliefs of management. Such statements are subject to risks and uncertainties that may cause actual results to be materially different from those that may be implied by such forward-looking statements contained in this press release. Important factors that could result in such differences include: changes in general economic, business and competitive conditions, effects of future judicial decisions, changes in regulation, exchange rate fluctuations and hiring and retention of its employees.
1. Epilepsy Foundation. About Epilepsy. http://www.epilepsyfoundation.org/aboutepilepsy/. Accessed 2/13/13.
2. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report. Epilepsy in Adults and Access to Care – United States, 2010. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6145a2.htm?s_cid=mm6145a2_w. Accessed 2/13/13.
3. Hesdorffer, DC, G Logroscino, EKT Benn, N Katri, G Cascino, and WA Hauser. 2011. "Estimating risk for developing epilepsy: A population-based study in Rochester, Minnesota." Neurology no. 76 (1):23-27.
4. The Lancet. "Wanted: a global campaign against epilepsy." The Lancet no. 380 (9848):1121.
Copyright©2012 PR Newswire.
All rights reserved